BDSX logo

Biodesix (BDSX) Company Overview

Profile

Full Name:

Biodesix, Inc.

Sector:

Healthcare

Country:

United States

IPO:

October 28, 2020

Indexes:

Not included

Description:

Biodesix (BDSX) is a biotechnology company focused on developing diagnostic tests for lung cancer. They use advanced technology to analyze blood samples, helping doctors make better treatment decisions. Their goal is to improve patient outcomes through personalized medicine and innovative testing solutions.

Key Details

Price

$0.85

Annual Revenue

$49.09 M(+28.46% YoY)

Annual EPS

-$0.64(+58.71% YoY)

Annual ROE

-414.09%

Beta

0.73

Events Calendar

Earnings

Next earnings date:

Mar 3, 2025

Recent quarterly earnings:

Nov 1, 2024

Recent annual earnings:

Mar 3, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Sep 16, 24 Scotiabank
Sector Outperform
Jul 26, 24 Craig-Hallum
Buy
May 13, 24 TD Cowen
Buy
May 3, 24 Lake Street
Buy
Mar 4, 24 Canaccord Genuity
Buy
Dec 7, 23 Canaccord Genuity
Buy
May 12, 22 Morgan Stanley
Equal-Weight
Apr 20, 22 Cowen & Co.
Outperform
Nov 17, 21 Morgan Stanley
Equal-Weight
May 12, 21 Morgan Stanley
Overweight

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Biodesix?
  • Does Biodesix pay dividends?
  • What sector is Biodesix in?
  • What industry is Biodesix in?
  • What country is Biodesix based in?
  • When did Biodesix go public?
  • Is Biodesix in the S&P 500?
  • Is Biodesix in the NASDAQ 100?
  • Is Biodesix in the Dow Jones?
  • When was Biodesix's last earnings report?
  • When does Biodesix report earnings?
  • Should I buy Biodesix stock now?

What is the ticker symbol for Biodesix?

The ticker symbol for Biodesix is NASDAQ:BDSX

Does Biodesix pay dividends?

No, Biodesix does not pay dividends

What sector is Biodesix in?

Biodesix is in the Healthcare sector

What industry is Biodesix in?

Biodesix is in the Diagnostics & Research industry

What country is Biodesix based in?

Biodesix is headquartered in United States

When did Biodesix go public?

Biodesix's initial public offering (IPO) was on October 28, 2020

Is Biodesix in the S&P 500?

No, Biodesix is not included in the S&P 500 index

Is Biodesix in the NASDAQ 100?

No, Biodesix is not included in the NASDAQ 100 index

Is Biodesix in the Dow Jones?

No, Biodesix is not included in the Dow Jones index

When was Biodesix's last earnings report?

Biodesix's most recent earnings report was on Nov 1, 2024

When does Biodesix report earnings?

The next expected earnings date for Biodesix is Mar 3, 2025

Should I buy Biodesix stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions